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Abstract The iron storage proteins, ferritins, are found in all
organisms which use iron. Here iron storage processes in the
Escherichia coli ferritin (EcFtnA) are compared with those in
human H-type ferritin (HuHF). Both proteins contain dinuclear
iron centres that enable the rapid oxidation of 2 Fe(II) by O2.
The presence of a third iron binding site in EcFtnA, although not
essential for fast oxidation, causes the O2/Fe ratio to increase
from 2 to 3^4. In EcFtnA the rate of iron oxidation falls
markedly after the oxidation of 48 Fe(II) atoms/molecule
probably because some of it remains at the oxidation site.
However a compensatory physiological advantage is conferred
because this iron is more readily available to meet the cell’s
needs.
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1. Introduction
The widespread occurrence of the iron storage proteins,
ferritins, emphasises their importance in physiological proc-
esses. Although conservation at the primary structural level
is relatively low, subunit folding, packing and iron storage
processes are remarkably conserved for all ferritins across
the living kingdom.
In vitro studies with animal and bacterial ferritins have
shown that the ¢rst steps leading to iron storage are the up-
take and catalytic oxidation of Fe(II) by the protein shell [1].
The resulting ferric iron is stored either as the mineral ferri-
hydrite (in animals) or as ferric phosphate (in bacteria).
Kinetic data obtained with recombinant human H chain
ferritin (HuHF) have indicated that the Fe(II) oxidation
step occurs at a dinuclear site within the protein shell (there
are 24 such sites per molecule, one for each of the 24 subunits
[2]). The dinuclear metal sites have been located at the centre
of the subunit 4-helix bundle by X-ray crystallographic anal-
ysis of Tb(III) derivatives and their function in iron uptake
con¢rmed with the aid of site-directed mutagenesis [2,3]. In
the ferritin of Escherichia coli (EcFtnA, the product of the
ftnA gene) such sites (A and B, Fig. 1) have been de¢ned by
direct observation of iron binding to the crystalline protein
[4].
The diiron centres of ferritins are similar in structure to
those found in a number of other proteins where they are
associated with reactions involving protein bound iron and
oxygen, e.g. the activation of oxygen in methane monooxy-
genase [5], tyrosyl radical formation in ribonucleotide reduc-
tase (RNR) [6], and desaturation of fatty acids in stearoyl-
ACP desaturase [7]. The di¡erent functionality of these pro-
teins is achieved by changes in the ligands and environment of
the dinuclear centre. Even when the immediate ligands of the
dinuclear centres are conserved, di¡erences in the rates of
oxidation and the reaction intermediates are observed with
di¡erent members of the ferritin family [8].
X-ray analysis has shown that each EcFtnA subunit binds
three iron atoms [4]. The two atoms of the dinuclear sites (A
and B) are separated by about 3.8 Aî and the third iron site, C,
lies on the inner surface of the protein shell at 7^8 Aî from the
A, B pair (Fig. 1). Four of the iron ligands at the dinuclear
centres of EcFtnA and HuHF are at equivalent positions:
E17/27, E50/62, H53/65, E94/107, the ¢fth ligands E130/E61
being non-equivalent (Fig. 2). Site C is unique to EcFtnA, its
ligands are E49, E126 and E130 (which alternates as a site B
or C ligand). These three glutamate residues (and also E129)
are conserved in all known Ftn sequences in which dinuclear
site ligands occur. The sequence of a new E. coli ferritin,
EcFtnB, has recently been de¢ned (accession number
D90832), only three of the dinuclear centre ligands are con-
served in this sequence (Fig. 2) and no function has been
identi¢ed for this ferritin. Based on an analysis of inter-sub-
unit interactions in EcFtnA and the aligned sequence of
EcFtnB, the formation of stable copolymers is unlikely. A
third metal (Tb3) binding site has also been located on the
inner surface of HuHF, but in a di¡erent position relative to
EcFtnA, its ligands are E61 and E64 [3]. Binding of iron at
this site has not been clearly established.
Compared to HuHF [1,2,9^13] few studies on the iron up-
take processes have been made with EcFtnA [11,14]. The stoi-
chiometry and kinetics of Fe(II) oxidation are here investi-
gated with the special reference to de¢ning the role of the
third iron binding site, C. The iron ligands of site A have
been substituted (E17A and E50A), as have those of site B
(E50A, the A^B bridging ligand; E94A and E130A) and those
of site C (E49A, E126A and E130A) (see Fig. 1). Two aro-
matic side chains near the dinuclear site have also been re-
placed (Y24F and W122F) as well as a glutamine residue
(Q127E) which, although not a direct ligand, is conserved in
the dinuclear sites of EcFtnA and HuHF.
2. Materials and methods
2.1. Site-directed mutagenesis, protein puri¢cation and iron removal
Overexpression of the ftnA gene and the production and overex-
pression of site-directed FtnA derivatives were carried out with the
pALTER-Ex1 system, as supplied by Promega UK (Southampton,
England). Overproduction of HuHF was performed as described in
[12]. Both, HuHF and EcFtnA ferritins were puri¢ed [15] with minor
modi¢cations [11]. Wild-type HuHF was treated with sodium dithion-
ite to remove endogenous iron prior to use [9]. Such treatment was
FEBS 20629 7-8-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 0 8 6 7 - 9
*Corresponding author. Fax: +44 (114) 2728697.
E-mail: p.harrison@sheffield.ac.uk
FEBS 20629 FEBS Letters 432 (1998) 213^218
not necessary for EcFtnA and its variants since they contained no
iron. Iron-free (apo) ferritins were used in all experiments.
Protein concentrations were determined with the Bio-Rad reagent.
The colour responses of all proteins were standardised using samples
whose concentration had been determined by amino acid analysis.
2.2. Oxygen consumption
Oxygen consumption during Fe(II) oxidation was measured with an
oxygen electrode (Rank Brothers, Cambridge) [2] using 1.5 ml of 3 WM
protein solution in 0.1 M MES bu¡er pH 6.5 and adding 48 Fe(II)
atoms/molecule as 5 Wl of ferrous ammonium sulphate in 1 mM
H2SO4.
2.3. Rapid kinetic experiments
Rapid kinetic experiments were carried out according to [11] using
an SX.17MV stopped-£ow instrument (Applied Photophysics, Leath-
erhead, UK) ¢tted with a sequential mixing option. Unless otherwise
stated, all quoted concentrations are the ¢nal concentrations after 1:1
mixing. The source of Fe(II) was ammonium ferrous sulphate
(99.997% pure, Aldrich Chemical Company, Dorset, England). Stock
solutions of Fe(II) were prepared in 5 mM H2SO4 and diluted to 50
WM H2SO4 immediately prior to use. In a typical experiment Fe(II), at
48 Fe atoms/molecule (96 WM), was mixed with 2 WM solution of
protein in 0.2 M MES bu¡er, pH 6.5. For measurements of progress
curves at 600 nm an additional cut-o¡ ¢lter (6 370 nm) was placed
between the monochrometer and the light pipe. All stopped-£ow ex-
periments were carried out at 25‡C.
The half time of Fe(II) oxidation was determined by the sequential
stopped-£ow assay described previously [11] using 0.25 WM protein in
0.1 M MES bu¡er pH 6.5 and 48 Fe(II) atoms/molecule. This assay
measures residual Fe(II) available for chelation with 1,10-phenanthro-
line. Only half times (t1=2) shorter than 900 s can be measured in this
assay.
For the sequential additions of 48 Fe(II) atoms/molecule the pro-
tein solution, 4 WM protein in 0.4 M MES bu¡er pH 6.5, was ¢rst
mixed (1:1), with either 50 WM H2SO4 or 192 WM Fe(II) in 50 WM
H2SO4. Between additions the protein/Fe solution was held in the
ageing loop for 1, 10 or 15 min before being mixed (1:1) with 96
WM Fe(II) in 50 WM H2SO4. Thus the protein solution to which
Fe(II) was added only in the second mixing gave the progress curve
for the ¢rst 48 Fe(II) atoms/molecule and that to which Fe(II) was
added twice gave the progress curve for the second addition. The
timing of the second addition of Fe(II) was chosen to ensure that
the ¢rst 48 Fe(II) atoms/molecule had been oxidised.
2.4. Discontinuous assay of Fe(II) oxidation
Residual Fe(II) was measured using ferrozine as an Fe(II) chelator
according to the method described in [13].
3. Results
3.1. Oxygen and Fe(II) stoichiometry
The stoichiometries of Fe(II) oxidation by dioxygen are
shown in Table 1 for EcFtnA and some of its variants. Com-
pared to the Fe(II)/O2 ratio of 2.3 obtained with HuHF, more
than three Fe(II) atoms were oxidised for each molecule of O2
consumed by EcFtnA. Site-directed substitutions of ligands at
site C in EcFtnA (E126A and E130A) reduced the Fe/O2 ratio
to that of HuHF whereas the stoichiometry was una¡ected by
changing a site A ligand (E17A) or residue W122 which is
situated close to the centre (W122F). These results suggest
that an intact site C is required to give the observed oxidation
stoichiometry of EcFtnA and that the proposed third site in
HuHF does not participate in the oxidation of iron at the
dinuclear centre.
The reason why the Fe/O2 ratio is lowered by the Y24F
substitution is unclear. This residue may be involved in the
transfer of electrons from Fe(II) at site C to the Fe-O2 com-
plex formed at the dinuclear centre.
3.2. E¡ects of site C modi¢cation on the rate of Fe(II)
oxidation
The half times of Fe(II) oxidation by EcFtnA and its var-
iants, as well as that of HuHF, are also shown in Table 1.
Replacing three of the dinuclear site ligands by alanine (E17A,
E50A or E94A) caused a dramatic increase in t1=2, whereas
replacing the site C ligands (E49A or E126A) produced only a
small reduction in the oxidation rate. Thus although site C is
involved in the oxidation of a third iron atom, binding of
Fe(II) at site C is not essential for fast Fe(II) oxidation at
the dinuclear centre. Because an E130A substitution had
only a small e¡ect on the half time of Fe(II) oxidation com-
pared to E50A or E94A, it is concluded that E130 is not an
essential ligand and that Fe(II) can be anchored at site B by
E50 and E94 alone.
The increase in t1=2 of oxidation observed with variant
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Table 1
E¡ects of site-directed substitutions in EcFtnA on the stoichiome-
tries and half times of the oxidation of 48 Fe(II) atoms/molecule
Fe(II) oxidation
Fe oxidised/O2 t1=2 (s)a Position of substituted residue
EcFtnA 3.5 0.43
W122F 3.9 0.38 near the dinuclear centre
Q127E n.d.b 0.42 at the dinuclear centre
E130A 1.8 1.0 site B or C ligand
E126A 1.8 1.27 site C ligand
Y24F 2.4 1.89 hydrogen bonded to a site B
ligand
E49A n.d. 2.4 site C ligand
E17A 3.6 281 site A ligand
E50A n.d. s 900 ligand for sites A and B
E94A n.d. s 900 site B ligand
HuHF 2.3 0.4
aHalf time of Fe(II) oxidation was measured using sequential stopped-
£ow with phenanthroline as Fe(II) chelator. 0.25 WM protein in 0.1 M
MES bu¡er pH 6.5 (only t1=2 less than W900 s can be measured).
bn.d., not done.
Fig. 1. The dinuclear centre of EcFtnA showing the iron binding
sites A and B and the neighbouring third iron site, C. Note that
E130 shown here as a ligand for Fe at site C, can also serve as a
ligand of Fe at site B.
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Y24F resembles the e¡ects of similar modi¢cations in HuHF
[2] and frog H ferritin [8]. Although Y24 is not a direct ligand
in either site A or B, it is hydrogen bonded to E94, which is
an essential ligand at site B.
3.3. E¡ects of site C modi¢cation on oxidation intermediates
With the exception of the dinuclear site variants E17A,
E50A and E94A which exhibited slow rates of Fe(II) oxida-
tion, all of the EcFtnA variants examined showed a transient
coloured oxidation intermediate which peaked at 0.5^2 s and
disappeared at 10^100 s (with 1 WM protein). Thus it would
appear that the intermediates are formed at or near the diiron
centres and their properties depend on the detailed structural
features of these centres. In EcFtnA (Fig. 3) and also in the
variants Q127E and Y24F [12], the transient intermediate had
a relatively high absorbance at 370 nm and a low absorbance
at 600 nm. However, in variants E130A, E49A and E126A,
the absorbance at 600 nm increased and that at 370 nm de-
creased so that they were nearly equal and the intermediate
was blue rather than yellow as in EcFtnA. The results also
showed that under the condition studied here, modi¢cation of
site C ligands alters the rates of both formation and decay of
the transient blue species (Fig. 3).
3.4. Post-oxidation e¡ects
In EcFtnA when 48 Fe(II) atoms/molecule are added, oxi-
dation was complete within 1 min yet spectral changes in the
UV and near-UV continued over a 20 min period (Fig. 4a).
These changes were greatly reduced or absent in site C var-
iants (Fig. 4b and c). The well-de¢ned isosbestic points ob-
served with EcFtnA suggest that one iron species is converted
into another. The absence of such changes in the variants
could mean that they occur before the ¢rst spectrum is re-
corded (about 20^40 s) or that the alterations in metal binding
that are responsible for the spectral changes do not occur in
these variants.
The spectral changes observed in EcFtnA were paralleled
by changes in the ability of EcFtnA to oxidise Fe(II). It had
been observed previously with HuHF [2] and BfHF [16] that
whereas the oxidation of the ¢rst 48 Fe(II) atoms/molecule
was fast, a subsequent aliquot was oxidised at a much slower
rate, and that it took several hours for the initial activity to be
restored. In EcFtnA the loss of activity, following the oxida-
tion of the ¢rst 48 Fe(II) atoms/molecule, was very marked
(Fig. 5a). Furthermore, the rate of Fe(II) oxidation became
progressively slower as the time between the ¢rst and second
addition was increased (Fig. 5a, d). Indeed there was no sign
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Fig. 2. Amino acid sequences around the diiron centre residues in HuHF, EcFtnA and EcFtnB.
Fig. 3. Stopped-£ow traces for the oxidation of 48 Fe(II) atoms/molecule by EcFtnA and variants. Reactions were followed at: a: 330 nm, b:
370 nm and c: 600 nm with 1 WM protein (¢nal) in 0.1 M MES bu¡er pH 6.5.
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Fig. 4. Post-oxidation spectral changes in EcFtnA and variants. UV di¡erence spectra were recorded after the addition of 48 Fe(II) atoms/mol-
ecule to 1 WM protein solution in 0.1 M MES bu¡er pH 6.5. a: EcFtnA, spectra are at 1, 2, 4, 8, 12 and 19 min after Fe(II) addition. b:
E49A, spectra are at 1, 3 and 5 min after Fe(II) addition. c: E130A, spectra are at 1, 5 and 8 min after Fe(II) addition.
Fig. 5. Comparison of the oxidation of the ¢rst 48 Fe(II) atoms/molecule with a second aliquot of 48 Fe(II) atoms/molecule added at di¡erent
times after the ¢rst addition. a^c: Sequential stopped-£ow progress curves recorded at 330 nm following the sequential mixing of the ferritin
solution with either one (1st) or two solutions of Fe(II). The second additions were made at the times speci¢ed for each trace. d^f: Discontinu-
ous assay using microtitre plates. In both assays the ¢nal protein concentration was 1 WM in 0.1 M MES bu¡er.
A. Tre¡ry et al./FEBS Letters 432 (1998) 213^218216
of recovery even after a 24 h interval. In contrast, with var-
iants E130A and E49A (which did not show the time-depend-
ent spectral changes, Fig. 4) there was an initial loss of activ-
ity after the ¢rst addition of 48 Fe(II) atoms/molecule but this
loss did not increase with time (Fig. 5b and c). Moreover, with
E130A the activity was restored 6 h after the ¢rst addition
(Fig. 5f) whereas with E49A the activity was essentially the
same for all additions (Fig. 5e). Thus it seems that modi¢ca-
tion of site C ligands has a very marked e¡ect on the rate of
regeneration of oxidative activity.
4. Discussion
The present results con¢rm that the initial event in the
sequestration of iron by EcFtnA is the oxidation of Fe(II)
at a dinuclear centre, as in HuHF. However, the two ferritins
show marked di¡erences which are seemingly due to the in-
volvement of a third iron atom bound at site C close to the
dinuclear centre of EcFtnA.
What then is the role of site C in EcFtnA? The increase in
oxidation stoichiometry from 2 in HuHF to 3^4 Fe(II)/O2 in
EcFtnA is due, at least in part, to oxidation of the third iron
at site C. It is uncertain whether a fourth Fe(II), in solution or
at a non-speci¢c protein site, is also oxidised to enable the full
reduction of dioxygen to water. There is an interesting parallel
with the R2 subunit of E. coli ribonucleotide reductase, where
the oxidation of two Fe(II) takes place at a dinuclear centre
together with the conversion of a nearby tyrosine to a tyrosyl
radical and the oxidation of a third Fe(II) at an unknown site
[17].
In EcFtnA even though site C participates in iron oxida-
tion, removal of site C ligands causes only a small reduction
in the primary oxidation rate compared with the e¡ects of
altering ligands of site A (E17) or site B (E94) or both
(E50). The role of site C appears to be in in£uencing oxida-
tion intermediates and the fate of the oxidised iron. The ob-
served changes in the transient intermediate could be directly
due to the loss of iron binding at site C or to changes in
charge distribution near the dinuclear centre. Loss of the
blue absorbance observed in HuHF variants Q127E and
A144E [2] suggests that changes in the absorbance spectrum
of the intermediate may be caused by the introduction of
negative charges in the vicinity of the dinuclear centre. The
interpretation of the spectral changes is uncertain but the
nature of the intermediates is clearly a¡ected by their environ-
ment.
Of more signi¢cance is the e¡ect of site C on the rate of
regeneration of activity. It is apparent (Fig. 5) that its pres-
ence leads to a prolonged reduction in ferroxidase activity as a
consequence of oxidising 48 Fe(II) atoms/molecule. Because a
high rate of oxidation depends on the availability of the di-
nuclear centres, the early recovery by site C variants suggests
that the absence of iron in site C increases the turnover rate of
these centres. Preliminary Moºssbauer spectroscopic studies on
the distribution of Fe(III) species in EcFtnA following the
oxidation 48 Fe(II) atoms/molecule have shown that the
movement of Fe(III) from dimers to core is very slow com-
pared with that in HuHF and that even at 24 h none of the
iron is found in clusters compared to 100% in HuHF [18].
This suggests that in EcFtnA most of the dinuclear centres
are still occupied 24 h after the initial oxidation. Moºssbauer
studies have shown that variant E130A is more similar to
HuHF than to EcFtnA, with most of the iron present in the
core at 6 h (Bauminger, Tre¡ry and Harrison, unpublished
work). Thus the regeneration of activity correlates with the
movement of iron into the protein cavity and the simultane-
ous recovery of Fe-free dinuclear centres.
The presence of the third iron site in EcFtnA therefore
confers two main advantages. The ¢rst involves the change
of iron oxidation stoichiometry from 2 Fe(II)/O2 in HuHF to
3^4 in EcFtnA. This avoids the production of reactive oxygen
species resulting instead in the complete reduction of dioxygen
to water and is of obvious bene¢t in vivo. The second bene¢t
is associated with the distribution of the oxidised iron in
EcFtnA. Thus although the prolonged loss of 98^99% of
the ferroxidase activity after the initial oxidation of 48
Fe(II) atoms/molecule may appear as a negative consequence
of the presence of site C, EcFtnA can still accumulate iron at
a signi¢cant rate (Fig. 5) and act as an iron storage protein.
Indeed it has been found by Moºssbauer spectroscopy that
when 144 Fe(II) atoms/molecule are added, 80% of this iron
is stored in the iron core at 24 h and only 20% (29 Fe atoms)
remains attached to the protein (Bauminger, Tre¡ry and Har-
rison, unpublished results). The retention of iron at the site of
oxidation may confer a physiological advantage. Thus in
EcFtnA the iron has been shown to be more readily available
to small chelators than iron in HuHF [19]. This observation
can now be explained by the di¡erence in the distribution of
iron: in EcFtnA it is retained at the binding sites in the pro-
tein shell under conditions in which in HuHF it more readily
moves to core. Hence EcFtnA may be well adapted to satisfy
the cellular demand for iron.
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